Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
MacFabe DF
Primary outcome Three hundred and one suicidality events occurred over 77 377 person years among GLP-1 receptor agonist users (crude incidence rate 3.9 per 1000 person years), and 1087 events occurred over 599 271 person years among DPP-4 inhibitor users (crude incidence rate 1.8 per 1000 person years) (table 3)
Routine consultation should be arranged if you notice: Persistent side effects affecting quality of life or treatment adherence Unexplained weight loss exceeding expected treatment effects Changes in your cancer surveillance schedule or new oncology appointments Difficulty managing blood glucose levels (for diabetic patients) If you are pregnant, planning pregnancy, or breastfeeding Any new medications prescribed by other specialists Do not stop taking Mounjaro without medical advice, particularly if using it for diabetes management
A., Yankaskas, J
The clinical information about each patient is summarized in the Table 1 below
